| Value | ₹25.00 Cr |
|---|
BSE filing, NSE: INTEGFD. Summary written from the filing by ALFA Finder's alert engine.
Integrated Proteins Ltd: key numbers
- Share price
- ₹13.08
- Market cap
- ₹244.8 Cr
- Revenue (annual)
- ₹9.94 Cr
- Net profit (annual)
- ₹0.22 Cr
- P/E (TTM)
- 389.3×Sector 38.3×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Integrated Proteins Ltd
All →Integrated Proteins Other Announcement
Integrated Proteins Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Integrated Proteins Management Change
Integrated Proteins Limited appointed Sandeep Mahadik as Non-Executive Independent Director and Ankita Shah as Secretarial Auditor, both effective September 30, 2026.
Integrated Proteins Annual General Meeting
Integrated Proteins Ltd held its Annual General Meeting on September 30, 2026. Shareholders considered resolutions regarding financial statements and company appointments.
Integrated Proteins Annual General Meeting
Integrated Proteins Ltd has announced its 33rd Annual General Meeting scheduled for September 30, 2026, via video conferencing to transact business including financial statement adoption.
Integrated Proteins Annual Report
Integrated Proteins Limited has released its 33rd Annual Report for the financial year 2025-26, containing financial statements and details for the upcoming annual general meeting.
Integrated Proteins Capital Structure Change
Integrated Proteins Limited has been assigned a new ISIN, INE177M01021, following a stock split. The change is effective from September 4, 2026.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.